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Summsl~ 
Human interferon-inducible  protein 10 (IP-10), a member of the family of the small secreted 
proteins called intercrine cytokines or chemokines, is secreted by interferon y-stimulated T cells, 
monocytes, endothelial cells, and keratinocytes. We have begun to explore the biological properties 
of IP-10 by cloning and overexpression in baculovirus and in bacterial protein expression systems. 
A  9.9-kD  protein  was  secreted  by  infected  insect  cells,  which  on  sodium  dodecyl 
sulfate-polyacrilamide gel electrophoresis comigrated with keratinocyte IP-10 and with f(22-98), 
a bacterial recombinant fragment lacking the signal sequence but containing all other residues 
of IP-10. All three reacted with antibodies  recognizing residues 10-98 (ollP-10) and 77-98 of 
IP-10 (ot22), demonstrating that it is secreted by keratinocytes and insect cells after removal of 
the signal sequence but without proteolysis of the COOH-terminal end. Purified riP-10 suppresses 
in vitro colony formation by early human bone marrow progenitor cells which need r-steel factor 
(rSLF) and rGM-CSF or rSLF and r-erythropoeitin (rEPO). The inhibition is dose dependent, 
is complete at concentrations >150 ng/ml, is prevented by preincubation of rlP-lO with o~IP-10, 
but not by c~22, and is seen with highly purified CD34 + cells, suggesting direct effect of riP- 
10 on the progenitors.  Combination of riP-10 and other chemokines at inactive concentrations 
inhibited colony formation in a synergistic manner, riP-10 did not affect colony formation in 
the absence of any growth factors or in the presence of rEPO or rGM-CSF but in absence of 
rSLF. The effects of IP-10 may be relevant to normal marrow function and might be harnessed 
to protect human hematopoietic progenitors from the cytotoxic effects of chemotherapy. 
W 
e have previously cloned human interferon-inducible 
protein 10 (IP-10), a protein secreted by keratinocytes, 
monocytes, and human endothelial cells after stimulation by 
rlFN-y (1, 2). DNA sequence analysis has demonstrated that 
IP-10 belongs to the intercrine cytokine or chemokine family 
of proteins  (3, 4),  so named for their chemotactic activity 
towards neutrophils, monocytes, T cells, basophils, and fibro- 
blasts. Some chemokines inhibit early subsets of bone marrow 
progenitors (5-11). This family is divided in two subgroups 
based on the arrangement of the first two of four conserved 
cysteines: the o~-subfamily with the C-X-C motif which is 
located  on  human  chromosome 4  (q12-21) and  includes 
GRO-a,/~-thromboglobulin, macrophage inflammatory pro- 
tein (MIP)-2ot, MIP-2B, IL-8, neutrophil-activating peptide 
(NAP)-2, and IP-10; and the B-subfamily with the C-C motif 
which is located on human chromosome 17(q11-32) and in- 
cludes MIP-la, MIP-1B,  macrophage-chemotactic and ac- 
tivating factor  (MCAF), and RANTES (3, 4). 
We have expressed IP-10 in bacterial and baculovirus vectors 
and used the purified recombinant protein to investigate its 
biological activity. We now clarify the model of IP-10 bio- 
synthesis, and demonstrate that it is secreted by keratinocytes 
and by baculovirus-infected  cells after the removal of the signal 
peptide, but without any detectable processing of the COOH- 
terminal end. Purified riP-10 directly inhibits early subsets 
of  granulocyte/macrophage progenitor  cells  (CFU-GM), 
muhipotential  granulocyte-erythroid-macrophage-megakaryo- 
cytic progenitors (CFU-GEMM) and erythroid burst-forming 
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in addition to rGM-CSF or rEPO, respectively. Inactive con- 
centrations of riP-10 combined with inactive concentrations 
of rMIP-lo~,  rMIP-2o~,  platelet factor 4  (PF4),  rlL-8,  or 
rMCAF result in synergistic inhibition of early progenitors. 
Materials and Methods 
All  chemicals were reagent  grade. Ficoll-Hypaque, protein 
A-Sepharose, and S-Sepharose were from Pharmacia (Piscataway, 
NJ). EX-CELL-400  was from JR Scientific  (Woodland, CA). The 
4.6 x 150-mm  C4 reverse  phase  column was from Vydac  (Hesperia, 
CA). The silver  staining  kit was from ICN (Cleveland,  OH). rIFN-3, 
was a gift from Dr. G. Garotta (Hoffman-LaRoche, Basel, Swit- 
zerland). Human rMIP-lol and rMIP-2cx were gifts from Dr. B. 
Sherry (Picower Institute,  Manhasset, NY).  Human rGM-CSF, 
human rlL-3 and human rSLF were gifts of the Immunex Corp. 
(Seattle, WA). We purchased human rEPO from Amgen Biolog- 
icals (Thousand Oaks, CA), human PF4 and rib8 from Sigma 
Chemical Co. (St. Louis, MO), and human rMCAF from Repro 
Tech Inc. (Rocky Hills, NJ). 
The cloning of IP-10 cDNA and the affinity purification of Abs 
against residues 10-98 (cdP-10), and 77-98 (o~22) or IP-10 have  been 
described (1, 2). 
Wild-type  baculovirus, Sf9 insect cells, and  transfer vector 
pVL1392 (12) were  provided by MD Summers (Texas AM Univer- 
sity, College Station,  TX).  Transfer vector pAcYM1 (13) was 
provided by D. Bishop (NERC Institute of  Virology,  Oxford, UK). 
The PstI fragment of the II)-10 cDNA was cloned in the PstI site 
of  pVL1392, and yielded  recombinant baculoviruses 8555 and 9094. 
For elimination of its 5' untranslated sequences, the IP-10 cDNA 
was digested with Nla3, the 375-nucleotide  fragment was purified, 
ligated to GATCCATG, restricted with BamHI, and cloned into 
the BamHI site of  pAcYM1, generating recombinant baculoviruses 
A213 and A221. We used standard  techniques  for isolation  of  recom- 
binant baculoviruses (12, 14) and sequenced (15) all junctions be- 
tween recombinant transfer vectors and I1)-10 cDNA to exclude 
cloning artifacts. For production of riP-10, Sf9 cells were infected 
with A221 (20 PFU/cell), 6-d supernatants were cleared at 100,000 
g for 1 h at 4~  dialyzed against 40 mM Na phosphate, pH 7.2, 
and loaded on a 15-ml Sepharose-S fast performance liquid chro- 
matography (FPLC) column. Proteins were eluted with a linear 
gradient of  0.002.0 M NaC1 in 40 mM Na phosphate, pH 7.2 (150 
ml), fractions containing riP-10 were identified with a dot blot im- 
munoassay (16) using cdP-10, and were loaded on a reverse-phase 
C4 HPLC column. Adsorbed riP-10 was eluted with a gradient 
of 25%  acetonitrile, 50%  propanol, 25%  H20 in 0.1% TFA, 
lyophilized, and resuspended in endotoxin-free PBS. 
With A (GGATCCATGGTACCTCTCTCTAGAACC)  as 5' and 
B (GGATCCATGGTTAAGGAGATCTTTTAGA)  as 3' primer we 
amplified  (17) a cDNA coding for f(22-98), a fragment lacking the 
signal peptide and extending from valine 22 to proline 98 of IP-10. 
With C(GGATCCATGGTTATGGATTCAGACATCTCTT)  as 3' 
and A as 5' primer we amplified a cDNA coding for f(22-77), a 
fragment extending from valine 22 to proline 77 and lacking the 
signal peptide and the last 21 residues of IP-10, but retaining all 
four cysteine residues and approximating the previously reported 
secreted form of  IP-10 (2). The PCR products were restricted with 
NcoI and cloned in the NcoI site of  pET-3d (provided  by F. Studier, 
Brookhaven National Laboratories,  Brookhaven, NY) eliminating 
all amino acid residues of $10 (18), and expressing the riP-10 frag- 
ments as nonfusion proteins with an added methionine at the 
NH2 terminus. The regions adjacent to and including the IP-10 
cDNA were sequenced (15) to exclude PCR and cloning errors. 
Lysogens  BL21(DE3) transformed  with recombinant  plasmids were 
induced with 0.4 mM isoprol0ylthiogalactoside  (18), recombinant 
f(22-98) was purified  (19) from refractile  bodies (20), dialyzed  against 
Ca/Mg-free PBS, and stored in 1-ml aliquots at  -70~  Protein 
concentration  was measured  by dye binding (21). Antiserum AS522 
was raised against purified recombinant f(22-98) as described (2). 
Natural human IP-10 was concentrated by TCA precipitation of 
serum-free medium from primary human keratinocytes after 24 h 
induction by rlFN-3/(2). 
Proteins were analyzed on 10020% gradient PAGE with 0.75 
M Tris-HC1, pH 8.45, in the stacking gel; 1.0 M Tris-HC1, pH 
8.45, in the separating gel; 0.2 M Tris HC1, pH 8.9, in the anode 
reservoir; 0.1 M Tris-0.1 M Tricine in the cathode reservoir; and 
0.1% SDS in all buffers (22). They were quantitated by densitom- 
etry after silver staining (23). Western blots were performed on 
Immunobilon-P  (16, 24). riP-10 was immunoprecipitated from 
[ssS]methionine-labeled Sf9 cells after boiling in 500/~1 of 0.2% 
SDS-50 mM Tris-HC1, pH 7.5, followed by the sequential addi- 
tion of NP-40 (final  concentration 1%), affinity-purified  Abs (final 
concentration 5/~g/ml), and protein A beads (25). The relative 
molecular mass of  IP-10 was estimated  from the mobilities  of  marker 
proteins of 43-14.3 kD. NH2-terminal sequencing was performed 
as described (26, 27). 
Human bone marrow CFU-GM, BFU-E, and CFU-GEMM of 
healthy  volunteers  were assayed  as described  with added  rEPO, rGM- 
CSF, rSLF (50 ng/ml), and other recombinant  or natural chemokines 
as indicated (6, 7, 11). Highly purified CD34 § cells (6, 11) were 
plated (500 cell/ml) in the presence of rEPO (1 U/ml), rSLF (50 
ng/ml), rGM-CSF (100 U/ml), and rlLo3 (200 U/ml), and yielded 
126  +  10, 60 +  10, and 17  +  5 CFU-GM, BFU-E, and CFU- 
GEMM per 500 plated cells, respectively. For reversal of inhibi- 
tion, we preincubated chemokines with fourfold molar excess of 
affinity-purified  Abs (~IP-10 or c~22) or with excess whole serum 
(AS522) in McCoy's medium at room temperature for 1 h. The 
mixture was added to human bone marrow cells and CFU-GM 
were assayed  in McCoy's medium supplemented with FCS, rSLF 
(50 ng/ml), and rGM-CSF (100 U/ml). For control, an equal  volume 
of similarly  incubated  McCoy's  medium was added  to cells. Statistical 
significance was determined with the Student's two-tailed test. 
Results 
Recombinant baculoviruses  8555,  9094, A213, and A221 
express riP-10 as a nonfusion protein. In 8555, the initiating 
ATG of the polyhedrin gene is mutated to ATT, and protein 
synthesis starts 118 nucleotides downstream, at the initiating 
ATG of the IP-10 cDNA. In 9094,  the IP-10 was inserted 
in the same location but in reverse orientation. In A221 and 
A2D, the initiating ATG of the polyhedrin gene is destroyed 
by deletion of nucleotides 2-751 of its coding region, and 
protein synthesis starts eight nucleotides downstream at the 
initiating ATG of IP-10. 
Analysis of protein synthesis after infection by 8555 and 
A221 demonstrated a major new band of 9.9 kD, similar in 
size to IP-10 without the signal sequence  (10.0 kD), and a 
minor band of 11.9 ICE), similar in size to IP-10 with the signal 
sequence (12.4 kD). Neither band was detected in uninfected 
cells or in cells infected with 9094 or with wild-type virus 
(Fig.  1 A). The 9.9-kD but not the 11.9-kD band was de- 
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(data not shown). Nonimmune serum did not precipitate any 
proteins from ceils infected with A221, but cdP-10 and o~22 
precipitated both bands (Fig.  1 B). Western blotting with 
cdP-10 and c~22 detected both bands in cells, but only the 
9.9-kD band in the medium (data  not shown). 
To precisdy define the molecular weight of baculovirus 
IP-10,  we used f(22-98)  and f(22-77)  as molecular weight 
markers and demonstrated that f(22-98)  and IP-10 derived 
from keratinocytes or baculovirus comigrated at 10.2 kD, and 
were recognized by olIP-10 and c~22. By contrast, f(22-77) 
migrated with a relative molecular mass of 6.2 kD, and was 
recognized by oelP-10 but not by ol22 (Fig. 2). The reactions 
of AS522 and c~IP-10 in immunoprecipitations  and Western 
blots were identical (results  not shown). 
Levels of riP-10 were 5-10 times higher after infection with 
A213 and A221 than after infection with 8555, and were not 
affected by FCS reaching 9% of the total protein in the su- 
pernatant of cells grown in EXCELL-400 (data not shown). 
With otlP-10 and a dot blot immunoassay, we purified riP- 
10 from supernatants of infected cells, and obtained a major 
peak on HPLC (Fig. 3 A) which was a single band on SDS- 
PAGE (Fig. 3 B, lanes S, F, and H) comigrating with purified 
bacterial f(22-98)  (Fig.  3 B, lane E).  The faint bands near 
the top of the gels correspond in size to keratins,  and were 
seen in unloaded lanes or in lanes loaded only with sample 
buffer.  Western blotting confirmed that the purified band 
represented riP-10, because it reacted with oelP-10 and ol22 
during all stages of purification (Fig.  2). 
Figure  2.  Western blot analysis of natural and riP-10. Keratinocyte IP- 
10 (KC), supernatants from A221-infected Sf9 cells (BI/), and representa- 
rive fractions from Sepharose-S  FPLC (BF) or C4 reverse  phase HPLC (BH) 
were analyzed by SDS-PAGE along with f(22-98) (E) or f(22-77) (JET). 
Duplicate  membranes  were  stained with ~IP-10 or ot22. 
NHz-terminal sequencing of baculovirus riP-10 demon- 
strated a major NH2-terminal sequence of VPLSRTVROT 
(66%)  and a minor sequence of RTVROT (34%),  both 
matching the sequence of IP-10 secreted by keratinocytes (2). 
Sequencing of f(22-98)  demonstrated a single  sequence of 
MVPLSRTVR(3rI'OISISNQPVN matching the sequence of 
secreted IP-10 (2) with an additional NH2-terminal methi- 
onine. The yield of purified riP-10 was 0.5 #g/ml of super- 
natant in the baculovirus system and 5/,g/ml of bacterial 
culture. 
Figure  1.  (A) Protein synthesis by wild-type and recombinant baculo- 
viruses. Cells were pulsed with [3SS]methionine 60-66 h after infection, 
washed,  boiled  in sample buffer, and analyzed by SDS-PAGE. The top 
of each  lane  designates  the  infecting  baculovirus.  (WT)  Wild-type 
baculovirus;  (SD)  uninfected  cells.  (B)  Immunoprecipitations  of cell- 
associated riP-10. SD cells were infected with A221, pulsed with [3SS]me- 
thionine 60-66 h after infection, boiled in SDS (7"), and immunoprecipi- 
rates of an equal number of cells by nonimmune serum (N/), triP-l,  or 
oe22 were analyzed with SDS-PAGE followed by fluorography, as desig- 
nated at the top of the corresponding  lanes. (*) The 11.9-kD form, and 
(**)  the 9.9-kD form of riP-10. 
Figure  3.  Purification  of riP-10  from bacuiovirus-infected  cells. (A) 
Reverse-phase HPLC or riP-10 purified from SD cells infected with A221. 
(/1230)  OD  of  the  ehate  at  230  nm;  (%B)  gradient  of propanol- 
acetonitrih-TFA.  (B) Analysis of the purification of riP-10 by SDS-PAGE. 
($) supernatants of A221-infected SD cells; (F) peak fraction of  S-Sepharose 
FPI.C; (/-/) peak fraction of the reverse-phase  HPLC analysis shown in (A); 
and (E) purified f(22-98) from Escherichia coil 
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CFU-GM, BFU-E, and CFU-GEMM. riP-10 (50 and 500 
ng/ml) did not affect colony formation by marrow cells plated 
in medium alone or in the presence of single growth factors 
(rEPO or rGM-CSF, data not shown). However, riP-10 sup- 
pressed colony formation of CFU-GM stimulated by rGM- 
CSF and rSLF, and BFU-E and CFU-GEMM stimulated by 
rEPO and rSLF. Concentrations of 1-10 ng/ml were inac- 
tive, but there was a dose-dependent inhibition between 25 
and 50 ng/ml. Maximal inhibition (50-60%) was seen at 
50-500 ng/ml of riP-10 (Fig. 4), representing complete sup- 
pression of the additional CFU-GM and BFU-E or CFU- 
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Figure 4.  Influence  of riP-10 on colony formation. CFU-GM were plated 
in the presence  of rGM-CSF (100 U/ml) and rSLF (50 ng/ml). CFU-GEMM 
and BFU-E were plated in the presence of rEPO (1 U/ml) and rSLF (50 
ng/ml). Percent inhibition  is the mean of three separate experiments with 
riP-10, and two to three experiments for the other chemokines. Symbols 
in the graphs are smaller than the SEM, which was always 412% of the 
mean percent change. Inhibition was based on control colony numbers 
for CFU-GM (59  +  2 to 106  _+  7), BFU-E (58  _+ 4 to 105  +  2), and 
CFU-GEMM (37 +  68 _+  1). ([-]) rlP-lO; (A) rMIP-lcq (ll) rMIP-2a; 
(O) PF4; (0) rlL-8; (A) rM-CAF. (*) Combination of all chemokines 
each at 50 ng/ml. 
GEMM colonies generated by the respective addition of rSLF 
to rGM-CSF or rEPO (data not shown). The dose-response 
was similar to that of rMIP-lo6 rMIP-2o~, PF4,  rlL-8, or 
rMCAF  (7,  11)  which were assessed in the same  assays. 
Whereas individual chemokines were inactive at concentra- 
tions <10 ng/ml, significant  suppression of colony forma- 
tion ~  <0.01) was seen when 0.01 ng/ml of riP-10 was com- 
bined with 0.01 ng/ml of rMIP-c~, rMIP-2ot, PF4, rlL-8, 
or rMCAE Combination of 0.1 ng/ml of riP-10 with 0.1 
ng/ml of any of these chemokines resulted in a 50-60% in- 
hibition of colony formation by CFU-GM, BFU-E, and CFU- 
GEMM ~  <0.001). This represented complete inhibition of 
the rSLF-dependent colonies,  and could not be suppressed 
further with a combination of riP-10, rMIP-lot, rMIP-2, PF4, 
rlL-8, and rMCAF each at 50 ng/ml (Fig. 4). In the presence 
of rlP-lO (100 ng/ml), colony formation by CD34 + cells 
was inhibited by 77% for CFU-GM ~  <0.01), by 58% for 
BFU-E (p <0.05), and by 82% for CFU-GEMM (p <0.05). 
The inhibitory activity of riP-10 was neutralized by Abs 
raised against whole IP-10 (cdP-10 and AS522)but not by 
Abs raised against the 22 COOH-terminal residues of IP-10 
(ol22). None of these Abs neutralized the inhibitory activity 
ofrMIP-lc~ or PF4, or affected the number of colonies grown 
in the absence of riP-10 (Table 1). 
Discussion 
We had previously suggested that IP-10 was secreted as 
a  6-7  kD-polypeptide after  cotranslational removal  of an 
NH2-terminal signal peptide, and posttranslational proteol- 
ysis of the COOH-terminal end. This conclusion was based 
on two observations, the first being an estimated relative mo- 
lecular mass of 6-7 kD (2) with SDS-PAGE on polyacryt- 
amide looser than used here (acrylamide/bisacrylamide 30/0.27 
vs 30/0.80). Keratinocyte and baculovirus riP-10 comigrated 
on tricine SDS-PAGE and had a relative molecular mass of 
10 kD,  suggesting no posttranslational processing of the 
COOH  terminus. However,  IP-10 migrates in SDS-PAGE 
in an area where the mobility of marker proteins is not linearly 
related  to the logarithm of their Mr, and consequently its 
estimated size could be inaccurate. Keratinocyte and baculovirus 
IP-10 comigrated with f(22-98), a fragment lacking the signal 
sequence but retaining all other residues of IP-10, but were 
larger than f(22-77), which approximates the previously de- 
scribed secreted form of IP-10 without the signal peptide and 
the last 21 amino acids (2). Protein sequencing demonstrated 
that the NH2 terminus of baculovirus IP-10 started at va- 
line 22 of the predicted sequence, and confirmed that Sf9 cells 
correctly remove the signal peptide. 
The second observation supporting the original model was 
the inability of c~22 to immunoprecipitate keratinocyte IP- 
10 when nonionic detergent was added first, followed by SDS, 
Ab, and protein A beads (2). However,  under these condi- 
tions, Ag-Ab-protein A interactions are not affected, because 
free SDS does not reach denaturing levels (28). When IP-10 
was first boiled in SDS followed by the addition of nonionic 
detergent in amounts sufficient to sequester SDS and permit 
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Colony formation  after preincubation  with 
Medium  otlP- 10  AS522  ot22 
Medium  61  _+  1  64  _+  1 (+2)  61  _+  1 (0)  63  _+ 2 (+3) 
rlP-lO  34  _+ 3 (-44)*  62  _+  1 (+2)  61  _+ 2 (0)  32  _+ 2 (-48)* 
rMIP-lot  33  _+  2 (-46)*  32  _+ 3 (-48)*  37  +  2 (-39)*  33  _+ 2 (-46)* 
PF4  31  +  1 (-49)*  34  +  2 (-44)*  36  _+  1 (-41)*  33  +  2 (-48)* 
CFU-GM grown with rGM-CSF (100 U/ml) and rSLF (50 ng/ml) are expressed as mean -+ 1 SEM per 10s plated cells. Chemokines were used 
at 50 ng/ml.  Purified f(22-98) was the source of riP-10. Values in parentheses designate percent inhibition from control. 
* Designates significant decrease ~ <0.001) from control. 
Ag-Ab interactions,  it was immunoprecipitated  by odP-10 
and oe22. Western blotting confirmed these results.  The reac- 
tions with antisera,  the identity of size,  and NH2-terminal 
sequences of keratinocyte, baculovirus,  and f(22-98),  dem- 
onstrate that IP-10 is secreted without significant processing 
of its  COOH-terminal  end. 
We demonstrated that  riP-10 is renatured  during purifi- 
cation and has similar biological activity with rMIP-lot, rMIP- 
2c~, PF4, rlL-8, or rMCAF (6, 7, 10, 11), abolishing colony 
formation by early bone marrow progenitors which require 
rSLF and rGM-CSF or rSLF and rEPO. Maximally effective 
concentrations did not abolish all colony formation, because 
colonies that  formed in the absence of rSLF,  and that pre- 
sumably represent later progenitors,  were not inhibited by 
riP-10. The inhibition of colony formation by highly purified 
CD34 + cells is consistent with a direct effect of riP-10 on 
early progenitors  (11). The combination of riP-10 and any 
one of rMIP-lot,  rMIP-2ot,  PF4, rlL-8,  or rMCAF  syner- 
gistically inhibited colony formation at concentrations 2,500 
times lower than required with single chemokines (Fig.  4), 
but its  molecular basis remains  undefined. 
The  inhibitory  activity  is  intrinsic  to  purified  riP-10, 
because it was specifically  neutralized by Abs against whole 
IP-10 (odP-10 and AS522), but not by o~22, that recognizes 
IP-10 only after SDS denaturation.  The results of the im- 
munoprecipitations  of riP-10 agree with the neutralization 
of its inhibitory activity, and suggest that the COOH-terminal 
end is buried in the quaternary structure of the native pro- 
tein. Quantities of natural IP-10 are too small for purification 
of amounts  sufficient for investigation  of its biological ac- 
tivity. The demonstration  that riP-10 has the same specific 
activity as the other chemokines in the colony suppression 
assay, supports the notion that bacteria and insect cells generate 
a protein with the correct disulfide arrangements,  and that 
the purification of riP-10 results in a completely renatured 
product.  Therefore,  the inability of riP-10 to activate neu- 
trophils  (Wirthmueller,  U.,  A.  Sarris,  and M.  Baggiolini, 
unpublished observations and 29), or to stimulate the growth 
of melanoma cells (Richmont, A., and A. Sarris, unpublished 
observations), probably reflect properties of the naturally oc- 
curring  protein. 
Since intravenous administration of rMIP-lot protected mu- 
fine hematopoietic progenitors from hydroxyurea and cyto- 
sine arabinoside (8,  9),  riP-10 may also be protective,  and 
may become clinically useful by allowing repetitive chemo- 
therapy administration  without  stem cell depletion. 
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